NCT02326350View on ClinicalTrials.gov

ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial

PHASE2TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 6, 2015

Primary Completion Date

November 23, 2018

Study Completion Date

November 23, 2018

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

Aspirin 75mg

Active treatment

DRUG

Lactose powder

Placebo

Sponsors
All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

collaborator

Northern Ireland Clinical Trials Unit

OTHER

lead

Belfast Health and Social Care Trust

OTHER

NCT02326350 - ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial | Biotech Hunter | Biotech Hunter